Skip to main content

CVE detail

CVE-2021-20334

A malicious 3rd party with local access to the Windows machine where MongoDB Compass is installed can execute arbitrary software with the privileges of the user who is running MongoDB Compass. This issue affects: MongoDB Inc. MongoDB Compass 1.x version 1.3.0 on Windows and later versions; 1.x versions prior to 1.25.0 on Windows.

CVSS 4.8 · MediumBuzz score 11.9

Buzz score

Why this CVE is surfacing

Buzz score total 11.9

This all-time snapshot uses the same composite formula as Trending across a 30-year evidence window, rather than a current rolling window.

Buzz score components · mention 6.9 · diversity 5.0 · KEV 0.0 · OTX 0.0 · PoC 0.0
Mention score
6.9
1 evidence mentions in the snapshot
Diversity score
5.0
1 sources across 1 categories
KEV score
0.0
No KEV entry observed
OTX score
0.0
0 OTX pulses
PoC score
0.0
0 repos · best confidence N/A
Best PoC traction
0
Maximum stars on a matched PoC repo

Why it matters now

Mention timeline

Total mentions
1
within the 30d window
Peak daily
1
highest bucket

Evidence

Source links by recency

Newest mentions first
1 source links · newest first
  • ABB Ability ZenonCISA Alerts

    Wastewater Countries/Areas Deployed: Worldwide Company Headquarters Location: Switzerland Vulnerabilities Expand All + CVE-2025-14847 Mismatched length fields in Zlib compressed protocol headers may allow a read of uninitialized heap memory by an unauthenticated client. This issue affects all MongoDB Server v7.0 prior to 7.0.28 versions, MongoDB Serve

    governmentwww.cisa.govAug 6, 2026, 12:00 PM

Exploit code

Public exploit repository references

Public PoC repositories are third-party, potentially unsafe artifacts. Treat their code as untrusted and use it only on authorized systems in an isolated, least-privilege environment. cvebuzz does not execute the code or verify that an exploit works.

0 repository references · best confidence N/A · max 0 stars
No public PoC repositories have been matched yet.

Related records

Similar CVEs

6 related CVEs with shared weakness or product evidence